Zimmer Biomet Holdings (ZBH) Share-based Compensation (2009 - 2026)

Zimmer Biomet Holdings' Share-based Compensation history runs 18 years deep, the most recent figure standing at $20.9 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 6.63% year-over-year to $20.9 million in Q1 2026; TTM through Mar 2026 was $90.1 million, a 117.63% increase from a year earlier, with the FY2025 full-year figure at $100.7 million, changed 0.3% from the prior year.
• Share-based Compensation declined to $20.9 million in Q1 2026 per ZBH's latest filing, from $47.4 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $121.3 million in Q4 2023 and bottomed at -$49.8 million in Q4 2024.
• The 5-year median for Share-based Compensation is $39.0 million (2023), against an average of $36.8 million.
• Across the five-year window, Share-based Compensation soared 370.16% in 2023 and plunged 141.06% in 2024, its largest moves.
• Year by year, Share-based Compensation stood at -$44.9 million in 2022, then surged by 370.16% to $121.3 million in 2023, then plunged by 141.06% to -$49.8 million in 2024, then jumped by 195.18% to $47.4 million in 2025, then sank by 55.91% to $20.9 million in 2026.
• Per Business Quant, the three latest ZBH Share-based Compensation figures stand at $20.9 million (Q1 2026), $47.4 million (Q3 2025), and $21.8 million (Q2 2025).